NWAM LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $855K | Buy |
1,541
+2
| +0.1% | +$1.11K | 0.07% | 243 |
|
|
2025
Q1 | $976K | Sell |
1,539
-130
| -8% | -$82.5K | 0.08% | 212 |
|
|
2024
Q4 | $1.19M | Sell |
1,669
-89
| -5% | -$63.4K | 0.07% | 239 |
|
|
2024
Q3 | $1.85M | Hold |
1,758
| – | – | 0.11% | 180 |
|
|
2024
Q2 | $1.85M | Buy |
1,758
+125
| +8% | +$131K | 0.54% | 34 |
|
|
2024
Q1 | $1.58M | Sell |
1,633
-6
| -0.4% | -$5.82K | 0.13% | 160 |
|
|
2023
Q4 | $1.44M | Sell |
1,639
-135
| -8% | -$119K | 0.12% | 179 |
|
|
2023
Q3 | $1.46M | Buy |
1,774
+8
| +0.5% | +$6.58K | 0.15% | 141 |
|
|
2023
Q2 | $1.27M | Buy |
1,766
+141
| +9% | +$101K | 0.1% | 192 |
|
|
2023
Q1 | $1.34M | Sell |
1,625
-112
| -6% | -$92K | 0.14% | 156 |
|
|
2022
Q4 | $1.25M | Buy |
1,737
+107
| +7% | +$77.2K | 0.11% | 184 |
|
|
2022
Q3 | $1.12M | Buy |
1,630
+17
| +1% | +$11.7K | 0.11% | 183 |
|
|
2022
Q2 | $961K | Sell |
1,613
-402
| -20% | -$240K | 0.09% | 208 |
|
|
2022
Q1 | $1.41M | Buy |
2,015
+26
| +1% | +$18.2K | 0.11% | 186 |
|
|
2021
Q4 | $1.26M | Buy |
1,989
+1,141
| +135% | +$721K | 0.1% | 205 |
|
|
2021
Q3 | $513K | Buy |
+848
| New | +$513K | 0.05% | 319 |
|